Hensoldt's May Reckoning: A Record Order Book Meets a Skeptical Market

Investors in German defense electronics specialist Hensoldt are facing a paradox. The company’s order book has swelled to a record €8.83 billion, providing revenue visibility deep into the decade, yet its shares languish more than 30% below their October 2025 peak of €115.10. This glaring disconnect between operational strength and stock performance sets the stage for a decisive few weeks, with quarterly results and a shareholder meeting poised to test the narrative.

The operational story is compelling. Order intake for 2025 hit a company record of €4.71 billion, a staggering 62% year-on-year increase. This surge has pushed the book-to-bill ratio to a robust 1.9x, indicating new contracts are being secured far faster than old ones are being fulfilled. Structurally, the company is anchored by reliable geopolitical tailwinds. Germany’s defense budget is set to reach a historic €108.2 billion in 2026, while European initiatives like the €150 billion SAFE program create a stable investment framework. Hensoldt has also secured a long-term supply contract through 2030 for 900,000 Gallium Nitride semiconductors—a critical component for modern radar systems—with plans to ramp up to an annual production of roughly 1,000 radar units from 2027.

Despite this formidable backdrop, the share price tells a different story. Recently closing at €78.32, the stock trades about 8.5% below its 200-day moving average. The market’s primary concern is execution: Hensoldt is struggling to convert its bulging order book into revenue quickly enough, hampered by production bottlenecks and a costly corporate overhaul. The company’s own 2026 revenue forecast of €2.75 billion sits roughly two percent below the analyst consensus, highlighting this gap.

Should investors sell immediately? Or is it worth buying Hensoldt?

This transformation is pressuring profitability. The introduction of a new SAP system and the "Operations 2.0" optimization program are weighing on margins. Management, however, remains committed to its guidance for an adjusted EBITDA margin between 18.5% and 19% for 2026. It is this narrow target range that has analysts divided. J.P. Morgan’s David H. Perry maintains a "Neutral" rating, recently trimming his price target from €90 to €85, arguing there is little room for operational disappointment. In contrast, Kepler Cheuvreux upgraded the stock from "Reduce" to "Hold," raising its target to €81, suggesting the risk-reward profile has become more balanced following sector-wide volatility.

A subtle vote of confidence has come from a major shareholder. BlackRock recently adjusted its stake, slightly reducing its total voting rights from 5.20% to 5.03% but remaining above the reportable threshold. Notably, the asset manager increased its direct shareholding from 2.53% to 2.61% while reducing exposure held via derivatives. This shift from indirect to direct ownership suggests a deliberate decision to maintain a core position.

Technically, the stock has shown tentative signs of life, climbing above its 100-day line to €78.70 on April 13. Yet it remains trapped in a downtrend that began in late January, with a critical resistance zone looming between €82 and €87.40. This area converges the downward trendline from October, the interim highs from February and March, and the 200-day moving average. A sustained breakout above this barrier is needed to signal a more meaningful technical recovery.

All eyes now turn to May for clarity. The first-quarter results on May 6 will be scrutinized for any early signs that the capacity expansion and restructuring are bearing fruit. Shortly after, the Annual General Meeting on May 22 will see shareholders vote on a proposed 10% dividend increase to €0.55 per share, with an ex-dividend date set for May 25. These events will determine if the stock’s recent technical bounce can evolve into a sustained rerating, finally bridging the chasm between Hensoldt’s powerful fundamentals and its subdued market valuation.

Ad

Hensoldt Stock: New Analysis - 15 April

Fresh Hensoldt information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Hensoldt analysis...

en | DE000HAG0005 | HENSOLDTS | boerse | 69157066 |